Solid Biosciences Inc. News
Solid Biosciences Slumps; Patient Had 'Adverse Events' in Trial
Solid Biosciences dropped after the developer of a muscular-dystrophy treatment reported that a patient had 'adverse events' in a drug trial.
Sarepta Sinks on Disappointing Gene-Therapy Study Results
Sarepta shares lose half their value after a gene-therapy study seen as a shoo-in treatment for Duchenne muscular dystrophy produces disappointing results.
5 Top Stock Gainers for Friday: Disney, FAT Brands
Walt Disney, vTv Therapeutics, Nanthealth, Solid Biosciences and FAT Brands are five of the top stock gainers for Friday.
Sarepta shares skyrocket on early results for DMD gene therapy
The Duchenne Muscular Dystrophy specialist announces early results that show a gene-based treatment for the debilitating disease may be just two years away.
Solid Biosciences Soars 41% in IPO Despite Late Disclosure About FDA Letter
Solid Bioscience planned its IPO for months, but waited until the day before its market debut on Friday, Jan. 26, to tell investors about an FDA hold on its key drug candidate.
'Big Short' Burry Warns That a Repeat of the 2008 Crisis Is in Sight
The legendary financier reiterates his warnings of a market collapse on the way.
Oil Volatility Returns, Pushing Gasoline Prices Higher
The 14-week decline in gasoline prices ended while two million people in Florida are still without power.
New Electric Vehicle Beats Tesla When it Comes to the Environment
A new EV would radically change how cars are made and that could be a threat to the market leader.
McDonald's Menu Adds a (Very) New Take on an Old Favorite
The fast-food giant has been hesitant to make changes like this, but Wendy's bold move may have forced it to.